CBIO Crescent Biopharma, Inc.
Crescent Biopharma, Inc. (CBIO) Institutional Ownership
What the institutions did with CBIO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| FMR LLC | 4.1M | 14.2% |
| BVF INC/IL | 2.7M | 9.4% |
| Fairmount Funds Management LLC | 2.7M | 9.4% |
| Venrock Adviser, LLC | 2.1M | 7.3% |
| Logos Global Management LP | 1.9M | 6.5% |
| FCPM III SERVICES B.V. | 1.7M | 5.8% |
| Balyasny Asset Management L.P. | 1.7M | 5.7% |
| Vestal Point Capital, LP | 1.6M | 5.6% |
| Opaleye Management Inc. | 1.3M | 4.5% |
| BlackRock, Inc. | 1.3M | 4.4% |
| TANG CAPITAL MANAGEMENT LLC | 1.2M | 4.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 767.8K | 2.6% |
| MILLENNIUM MANAGEMENT LLC | 403.9K | 1.4% |
| GEODE CAPITAL MANAGEMENT, LLC | 384.6K | 1.3% |
| JENNISON ASSOCIATES LLC | 378.5K | 1.3% |
| RTW INVESTMENTS, LP | 372.9K | 1.3% |
| NEXTBio Capital Management LP | 372.9K | 1.3% |
| Remedium Capital Partners, LLC | 361.3K | 1.2% |
| STATE STREET CORP | 315.6K | 1.1% |
| AMERIPRISE FINANCIAL INC | 302.6K | 1.0% |
| Point72 Asset Management, L.P. | 300.0K | 1.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 275.6K | 0.9% |
| MARSHALL WACE, LLP | 214.3K | 0.7% |
| PERCEPTIVE ADVISORS LLC | 206.9K | 0.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 188.8K | 0.6% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| Logos Global Management LP | Increased | 482.5K | 1.9M | +1.4M |
| BlackRock, Inc. | Increased | 115.7K | 1.3M | +1.2M |
| Deep Track Capital, LP | Sold Out | 453.7K | 0 | -453.7K |
| Remedium Capital Partners, LLC | New | 0 | 361.3K | +361.3K |
| AMERIPRISE FINANCIAL INC | New | 0 | 302.6K | +302.6K |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 104.2K | 384.6K | +280.4K |
| STATE STREET CORP | Increased | 39.1K | 315.6K | +276.5K |
| Alyeska Investment Group, L.P. | Sold Out | 264.0K | 0 | -264.0K |
| GOLDMAN SACHS GROUP INC | Sold Out | 228.5K | 0 | -228.5K |
| JENNISON ASSOCIATES LLC | Increased | 153.0K | 378.5K | +225.5K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold Out | 213.6K | 0 | -213.6K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New | 0 | 188.8K | +188.8K |
| STEMPOINT CAPITAL LP | New | 0 | 182.4K | +182.4K |
| Balyasny Asset Management L.P. | Increased | 1.5M | 1.7M | +152.9K |
| Vestal Point Capital, LP | Increased | 1.5M | 1.6M | +130.0K |
| NORTHERN TRUST CORP | Increased | 17.2K | 138.8K | +121.5K |
| SECTORAL ASSET MANAGEMENT INC | New | 0 | 121.3K | +121.3K |
| UBS Group AG | Increased | 82.7K | 175.2K | +92.5K |
| Hudson Bay Capital Management LP | Sold Out | 88.9K | 0 | -88.9K |
| MILLENNIUM MANAGEMENT LLC | Increased | 323.6K | 403.9K | +80.3K |
| SILVERARC CAPITAL MANAGEMENT, LLC | Reduced | 130.5K | 59.1K | -71.4K |
| TWO SIGMA INVESTMENTS, LP | Increased | 115.8K | 186.9K | +71.0K |
| Blackstone Inc. | New | 0 | 62.6K | +62.6K |
| Y-Intercept (Hong Kong) Ltd | New | 0 | 50.8K | +50.8K |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | New | 0 | 50.3K | +50.3K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.